Select a company


Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted


  • Biotech
  • Healthcare
  • Cleantech
  • Technology
  • Other


  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other


  • IP Group
  • IP Venture Fund
  • IP Venture Fund II
  • Top 10 Holdings
    by value
Energy and Renewables

University: Southampton

Company Stage: Quoted


Ilika Technologies is focused on high throughput methods of screening, synthesising and characterising very large numbers of new materials.

High throughput combinatorial chemistry has already had a significant impact on the pharmaceutical industry where the technique is widely used within the drug discovery process to synthesise and screen large numbers of new compounds. Ilika has been formed to introduce similar techniques to other chemical and materials industries, with the objective of dramatically accelerating the discovery of new materials with commercial value.

As at 30 June 2014

IP Group holding

IP Venture Fund* holding



*IP Group has a 10%
economic interest in IP
Venture Fund

Holdings represent undiluted beneficial equity interest excluding debt


Related news

22 Jan 2015
21 Nov 2014

There is currently no news available.

More portfolio news